VTRS Viatris Inc. - Common Stock
Viatris Inc. - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.
और पढ़ें
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.
The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community.
Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue. In 2026, Viatris ranked 100 on Time Magazine's World's Most Impactful Companies.
History
On November 16, 2020, Upjohn merged with Mylan in a Reverse Morris Trust transaction and changed its name to Viatris. At that time, Michael Goettler became chief executive officer. Following the combination, the company began trading on the NASDAQ using the ticker symbol VTRS. In December 2020, the company announced a cost-reducing restructuring plan that would impact up to 20% of its global workforce, or 9,000 jobs at its facilities around the world.
In 2021, Viatris was ranked 5th by Fortune on its annual "Change the World" list for having "transformed the treatment of HIV around the world in the [previous] five years through the first low-cost antiretroviral drug for first-line treatment of HIV and a children's version in the form of fruit-flavored tablets that dissolve in liquid. In February 2022, Viatris announced an agreement where it will contribute to Biocon Biologics its biosimilars portfolio and related commercial and operational capabilities in exchange for up to $3.335 billion, including a stake of at least 12.9% in Biocon Biologics. The transaction was completed in November 2022. In November 2022, the business agreed to acquire Oyster Point Pharma and Famy Life Sciences for an aggregate of $700–750 million to create an ophthalmology division. The acquisitions closed in January 2023.
In 2022 and 2024, Viatris was recognized by Forbes as one of the world's best employers and by Newsweek as one of America's most responsible companies. On April 1, 2023, Scott A. Smith became Viatris' CEO, succeeding Michael Goettler. Smith previously served on the company's board since 2022. In April 2023, Viatris was recognized by LinkedIn as one of the 25 best companies to work for in India, and one of the 25 best companies offering career development in Ireland. In May 2023, USA Today included Viatris in its list of 400 US companies that have reduced their greenhouse gas emissions intensity from 2019 to 2021. In June 2023, Viatris was named to the Forbes Global 2000 list of the world's largest companies. In October 2023, Viatris reached agreements to divest from almost all of its OTC business, its women’s healthcare business, and its India-based active pharmaceutical ingredients business for a total of about $3.6 billion.
In late December 2024, Viatris disclosed that the U.S. FDA had issued a warning letter and an import alert concerning the company's drug-making facility in Indore, India. The import alert affects 11 actively distributed products, which will no longer be accepted into the U.S. until the warning letter is lifted, while four products were conditionally exempted due to shortages. The violations cited by the FDA included subpar quality control and improper management of manufacturing defect. In response, the company announced that it has taken corrective and preventative actions.
Predecessors
The following is an illustration of the company's major mergers and acquisitions and historical predecessors:
Products
The company produces and sells a variety of medicines, with 1,400 approved therapeutic molecules in its portfolio. It owns brands (like Viagra, Xanax, Lipitor), generics, including branded and complex generics, biosimilars, and over-the-counter (OTC) drugs and active pharmaceutical ingredients. Viatris products cover therapeutic areas including cardiovascular, infectious disease, oncology, immunology, CNS and anesthesia, women's healthcare, diabetes and metabolism, gastroenterology, respiratory and allergy, and dermatology.
The following products have been newly launched or received regulatory approvals since Viatris was established include:
Dolutegravir: In December 2020, received FDA approval to treat children with HIV/AIDS in low to middle income countries. The formulation is strawberry-flavored to make it easier to give to children and was made available at a 75% discount compared to previous treatments.
Breyna (budesonide and formoterol fumarate dihydrate inhalation aerosol): In March 2022, received approval from the US FDA in March 2022 as the first generic version of Symbicort for the treatment of asthma and COPD.
GA Depot (long-acting version of glatiramer acetate): In August 2023, received New Drug Application acceptance from the US FDA as a once-monthly injection for the treatment of relapsing forms of multiple sclerosis.
Abacavir/dolutegravir/lamivudine: In September 2023, received tentative US FDA approval for a New Drug Application through the President's Emergency Plan for AIDS Relief (PEPFAR) for the treatment of HIV-1 infection in pediatric patients.
Ryzumvi (phentolamine ophthalmic solution 0.75%): In September 2023, received FDA approval for the treatment of mydriasis caused by adrenergic agonist or parasympatholytic agents or a combination of those drugs. It was previously known as Nyxol.
Partnerships
Following the formation of Viatris, the company became a member of the Biosimilars Forum, a trade organization that advocates for greater biosimilar usage. Viatris partnered with the American College of Cardiology, the NCD Alliance, and the World Heart Federation to create the NCD Academy, a platform to help fight non-communicable diseases around the world.
In December 2020, the company worked with Sesame Workshop to create resources to help children and their caregivers manage their social and emotional needs impacted by the COVID-19 pandemic. In April 2021, the company partnered with Atomo Diagnostics and Unitaid to expand access to HIV self-testing to 135 countries and lower the price of the tests by around 50%.
In February 2024, Viatris entered into an agreement with Idorsia to collaborate on global research and development and the commercialization rights to Phase 3 pharmaceuticals selatogrel, a cardiac medication, and cenerimod, a novel immunology medication used to treat systemic lupus erythematosus. The agreement includes the potential to add more assets in the future.
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
VTRS स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
VTRS स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
लाभांश यील्ड, भुगतान अनुपात, लाभांश इतिहास, 5Y CAGR
| एक्स-डेट | राशि |
|---|---|
| 22 मई 2026 | $0.1200 |
| 9 मार्च 2026 | $0.1200 |
| 24 नवमबर 2025 | $0.1200 |
| 22 अगस्त 2025 | $0.1200 |
| 23 मई 2025 | $0.1200 |
| 10 मार्च 2025 | $0.1200 |
| 22 नवमबर 2024 | $0.1200 |
| 23 अगस्त 2024 | $0.1200 |
| 23 मई 2024 | $0.1200 |
| 8 मार्च 2024 | $0.1200 |
| 22 नवमबर 2023 | $0.1200 |
| 23 अगस्त 2023 | $0.1200 |
| 23 मई 2023 | $0.1200 |
| 8 मार्च 2023 | $0.1200 |
| 22 नवमबर 2022 | $0.1200 |
| 23 अगस्त 2022 | $0.1200 |
| 23 मई 2022 | $0.1200 |
| 23 फ़रवरी 2022 | $0.1200 |
| 22 नवमबर 2021 | $0.1100 |
| 23 अगस्त 2021 | $0.1100 |
VTRS विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
- मजबूत खरीद 4 23.5%
- खरीदें 7 41.2%
- होल्ड 5 29.4%
- बेचें 1 5.9%
- मजबूत बिक्री 0 0.0%
12-महीने का मूल्य लक्ष्य
8 विश्लेषक · 2026-08-19Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
| Period | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|
| 30 जून 2026 | $0.69 | $0.61 | 0.08% |
| 31 मार्च 2026 | $0.59 | $0.51 | 0.08% |
| 31 दिसमबर 2025 | $0.57 | $0.54 | 0.03% |
| 30 सितमबर 2025 | $0.67 | $0.63 | 0.04% |
| 30 जून 2025 | $0.62 | $0.57 | 0.05% |
| 31 मार्च 2025 | $0.50 | $0.50 | 0.00% |
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| VTRS | — | -4.2 | -3.0% | -24.6% | -23.2% | 35.1% |
| MRK | — | 14.5 | 1.3% | 28.1% | 36.9% | — |
| PFE | — | 18.3 | -1.7% | 12.4% | 8.9% | — |
| BMY | — | 15.6 | -0.22% | 14.6% | 40.5% | — |
| RPRX | — | 21.7 | 5.1% | 32.4% | 8.0% | — |
| ZTS | $53.46B | 20.9 | 2.3% | 28.2% | 66.0% | — |
| CORT | $3.69B | 42.4 | 12.8% | 13.1% | 15.5% | — |
| ELAN | $11.25B | -48.1 | 6.2% | -4.9% | -3.5% | 55.0% |
| AXSM | $9.29B | -49.6 | 65.5% | -28.7% | -227.0% | — |
| CRNX | $4.45B | -9.4 | 640.7% | -6046.2% | -43.0% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण 17
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.30B | $14.74B | $15.43B | $16.26B | $17.89B | $11.95B | $11.50B | $11.43B | |
| Cost of Revenue | $9.29B | $9.12B | $8.99B | $9.77B | $12.31B | $8.15B | $7.60B | $7.43B | |
| Gross Profit | $5.01B | $5.62B | $6.44B | $6.50B | $5.58B | $3.80B | $3.90B | $4.00B | |
| R&D Expense | · | · | · | · | $751M | $555M | $640M | $704M | |
| SG&A Expense | $3.79B | $4.10B | $4.07B | $4.18B | $4.53B | $3.34B | $2.56B | $2.44B | |
| Operating Expenses | $7.68B | $5.61B | $5.67B | $4.88B | $5.61B | $4.01B | $3.18B | $3.10B | |
| Operating Income | $-2.66B | $10M | $766M | $1.61B | $-34M | $-211M | $716M | $906M | |
| Interest Expense | $471M | $550M | $573M | $592M | $636M | $498M | $517M | $542M | |
| Other Non-op | $-531M | $-83M | $10M | $1.79B | $6M | $-13M | $-44M | $-65M | |
| Pretax Income | $-3.67B | $-623M | $203M | $2.81B | $-664M | $-721M | $154M | $298M | |
| Income Tax | $-150M | $11M | $148M | $735M | $605M | $-51M | $138M | $-54M | |
| Net Income | $-3.51B | $-634M | $55M | $2.08B | $-1.27B | $-670M | $17M | $352M | |
| EPS (Basic) | $-3.00 | $-0.53 | $0.05 | $1.71 | $-1.05 | $-1.11 | $0.03 | $0.69 | |
| EPS (Diluted) | $-3.00 | $-0.53 | $0.05 | $1.71 | $-1.05 | $-1.11 | $0.03 | $0.68 | |
| Shares (Basic) | · | · | 1,200,300,000 | 1,212,100,000 | 1,208,800,000 | 601,200,000 | 515,700,000 | 514,500,000 | |
| Shares (Diluted) | · | · | 1,206,900,000 | 1,217,400,000 | 1,208,800,000 | 601,200,000 | 516,500,000 | 516,500,000 | |
| EBITDA | $135M | · | · | · | · | · | · | · |
बैलेंस शीट 30
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.32B | $735M | $992M | $1.26B | $701M | $844M | $476M | $388M | |
| Short-term Investments | · | · | · | · | · | $39M | $27M | · | |
| Receivables | $3.03B | $3.22B | $3.70B | $3.81B | $4.27B | $4.84B | $3.06B | · | |
| Inventory | $4.00B | $3.85B | $3.47B | $3.52B | $3.98B | $5.47B | $2.67B | · | |
| Prepaid Expense | $1.44B | $1.71B | $2.03B | $1.81B | $1.96B | $1.71B | $552M | · | |
| Other Current Assets | $136M | $387M | $271M | $328M | $1.47B | $1.24B | $286M | · | |
| Current Assets | $9.79B | $9.52B | $12.98B | $10.64B | $10.90B | $12.87B | $6.76B | · | |
| PP&E (Net) | $2.61B | $2.67B | $2.76B | $3.02B | $3.19B | $3.46B | $2.15B | · | |
| PP&E (Gross) | $5.13B | $4.87B | $4.77B | $5.08B | $5.59B | $5.72B | $4.12B | · | |
| Accum. Depreciation | $2.52B | $2.20B | $2.01B | $2.06B | $2.40B | $2.26B | $1.97B | · | |
| Goodwill | $6.75B | $9.13B | $9.87B | $10.43B | $12.11B | $12.35B | $9.59B | $9.75B | |
| Intangibles | $15.10B | $17.07B | $19.18B | $22.61B | $26.13B | $29.68B | $11.65B | · | |
| Other Non-current Assets | $1.87B | $2.36B | $2.21B | $2.40B | $1.17B | $1.05B | $405M | · | |
| Total Assets | $37.19B | $41.50B | $47.69B | $50.02B | $54.84B | $61.55B | $31.26B | · | |
| Short-term Debt | · | · | · | $0 | $1.49B | $1.10B | $0 | · | |
| Current Liabilities | $7.09B | $5.78B | $7.78B | $6.75B | $9.88B | $10.56B | $5.57B | · | |
| Capital Leases | $178M | $179M | $165M | $181M | $201M | $230M | $176M | · | |
| Deferred Tax | $892M | $1.11B | $1.74B | $2.43B | $2.81B | $3.12B | $1.63B | · | |
| Other Non-current Liabilities | $2.01B | $1.94B | $1.52B | $1.76B | $1.93B | $2.48B | $961M | · | |
| Total Liabilities | $22.48B | $22.87B | $27.22B | $28.95B | $34.35B | $38.60B | $19.37B | · | |
| Long-term Debt | $14.41B | $14.05B | $18.13B | $19.27B | $21.59B | $24.74B | $12.72B | · | |
| Total Debt | $14.41B | · | · | · | · | · | · | · | |
| Common Stock | $12M | $12M | $12M | $12M | $12M | $12M | $6M | · | |
| Paid-in Capital | $18.80B | $18.92B | $18.81B | $18.65B | $18.54B | $18.44B | $8.64B | · | |
| Retained Earnings | $-388M | $3.42B | $4.64B | $5.18B | $3.69B | $5.36B | $6.03B | · | |
| Treasury Stock | $1.01B | $504M | $252M | $0 | $0 | $0 | $1000M | · | |
| AOCI | $-2.71B | $-3.21B | $-2.75B | $-2.76B | $-1.74B | $-858M | $-1.80B | · | |
| Stockholders' Equity | $14.71B | $18.64B | $20.47B | $21.07B | $20.49B | $22.95B | $11.88B | $12.17B | |
| Liabilities + Equity | $37.19B | $41.50B | $47.69B | $50.02B | $54.84B | $61.55B | $31.26B | · | |
| Shares Outstanding | · | · | · | · | · | · | 100 | · |
नकदी प्रवाह 19
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $2.80B | $2.89B | $2.74B | $3.03B | $4.51B | $2.22B | $2.02B | $2.11B | |
| Stock-based Comp | $178M | $146M | $181M | $116M | $111M | $79M | $57M | $-3M | |
| Deferred Tax | $-476M | $-768M | $-387M | $-26M | $676M | $-213M | $-193M | $-264M | |
| Amort. of Intangibles | $2.35B | $2.35B | $2.32B | $2.50B | $2.70B | $1.61B | $1.58B | $1.61B | |
| Restructuring | · | · | · | · | $50M | $50M | $105M | · | |
| Other Non-cash | $3.33B | · | · | · | · | · | · | · | |
| Operating Cash Flow | $2.32B | $2.30B | $2.90B | $3.00B | $3.02B | $1.23B | $1.80B | $2.34B | |
| CapEx | $379M | $326M | $377M | $406M | $457M | $243M | $213M | $252M | |
| Investing Cash Flow | $-428M | $1.80B | $-864M | $1.47B | $-118M | $-301M | $-525M | $-1.21B | |
| Debt Issued | $0 | $0 | $300.0K | $1.88B | $1.71B | $983M | $7M | $2.58B | |
| Net Debt Issued | $-100.0K | · | · | · | · | · | · | · | |
| Stock Issued | $3M | $2M | $3M | $3M | $0 | $0 | · | · | |
| Stock Repurchased | $500M | $250M | $250M | $0 | $0 | $0 | $0 | $432M | |
| Net Stock Activity | $-498M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-1.29B | $-4.33B | $-2.30B | $-3.88B | $-3.01B | $-606M | $-1.17B | $-1.09B | |
| Net Change in Cash | $612M | $-258M | $-269M | $556M | $-144M | $359M | $102M | $19M | |
| Taxes Paid | $445M | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.94B | · | · | · | · | · | · | · | |
| Levered FCF | $1.49B | · | · | · | · | · | · | · |
लाभप्रदता 8
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 35.1% | · | · | · | · | · | · | · | |
| Operating Margin | -18.6% | · | · | · | · | · | · | · | |
| Net Margin | -24.6% | · | · | · | · | · | · | · | |
| Pretax Margin | -25.6% | · | · | · | · | · | · | · | |
| EBITDA Margin | 0.95% | · | · | · | · | · | · | · | |
| ROA | -8.9% | · | · | · | · | · | · | · | |
| ROE | -23.2% | · | · | · | · | · | · | · | |
| ROIC | -8.8% | · | · | · | · | · | · | · |
तरलता और शोधन क्षमता 5
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | · | · | · | · | · | · | · | |
| Quick Ratio | 0.6 | · | · | · | · | · | · | · | |
| Debt / Equity | 1.0 | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.8 | · | · | · | · | · | · | · | |
| Interest Coverage | -5.7 | · | · | · | · | · | · | · |
दक्षता 3
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | · | · | · | · | · | · | · | |
| Inventory Turnover | 2.4 | · | · | · | · | · | · | · | |
| Receivables Turnover | 4.6 | · | · | · | · | · | · | · |
विकास दरें 5
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -3.0% | -4.5% | -5.1% | -9.1% | 49.7% | · | · | · | |
| Revenue CAGR 3Y | -4.2% | -6.2% | 8.9% | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.7% | · | · | · | · | · | · | · | |
| EPS YoY | · | · | -97.1% | · | · | · | · | · | |
| Net Income YoY | · | · | -97.4% | · | · | · | · | · |
मूल्यांकन (TTM) 6
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14.30B | $14.74B | $15.43B | $16.26B | $17.89B | $11.95B | $11.50B | · | |
| Net Income TTM | $-3.51B | $-634M | $55M | $2.08B | $-1.27B | $-670M | $17M | · | |
| Market Cap | · | · | · | · | · | · | $2.0K | · | |
| P/E | -4.2 | -23.5 | 216.6 | 6.5 | -12.9 | -16.9 | 670.0 | · | |
| P/S | · | · | · | · | · | · | 0.0 | · | |
| Earnings Yield | -24.1% | -4.3% | 0.46% | 15.4% | -7.8% | -5.9% | 0.15% | · |
आय विवरण 16
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.76B | $3.52B | $3.70B | $3.76B | $3.58B | $3.25B | $3.53B | $3.75B | $3.80B | $3.66B | $3.84B | $3.94B | $3.92B | $3.73B | $3.88B | $4.08B | |
| Cost of Revenue | $2.30B | $2.36B | $2.56B | $2.39B | $2.25B | $2.09B | $2.31B | $2.29B | $2.35B | $2.16B | $2.24B | $2.25B | $2.31B | $2.19B | $2.60B | $2.33B | |
| Gross Profit | $1.46B | $1.16B | $1.15B | $1.37B | $1.33B | $1.16B | $1.22B | $1.46B | $1.45B | $1.50B | $1.60B | $1.69B | $1.61B | $1.54B | $1.27B | $1.75B | |
| R&D Expense | $248M | $249M | · | $250M | $219M | $222M | · | $198M | $204M | $200M | · | $211M | $208M | $183M | · | $175M | |
| SG&A Expense | $1.13B | $929M | $1.03B | $887M | $929M | $948M | $1.05B | $1.00B | $1.04B | $1.02B | $1.03B | $1.05B | $1.03B | $959M | $1.27B | $1.02B | |
| Operating Expenses | $1.45B | $1.24B | $1.34B | $1.19B | $1.10B | $4.04B | $1.39B | $1.23B | $1.69B | $1.30B | $2.05B | $1.24B | $1.24B | $1.14B | $1.48B | $1.19B | |
| Operating Income | $6M | $-80M | $-193M | $179M | $233M | $-2.88B | $-180M | $226M | $-240M | $204M | $-454M | $452M | $369M | $400M | $-201M | $560M | |
| Interest Expense | $121M | $120M | $120M | $120M | $117M | $116M | $120M | $146M | $146M | $138M | $141M | $142M | $144M | $147M | $147M | $153M | |
| Other Non-op | $50M | $-48M | $-31M | $-67M | $-334M | $-99M | $-226M | $10M | $-6M | $139M | $-260M | $92M | $108M | $70M | $1.82B | $21M | |
| Pretax Income | $-64M | $-247M | $-343M | $-8M | $-217M | $-3.10B | $-526M | $90M | $-392M | $205M | $-855M | $402M | $333M | $323M | $1.47B | $428M | |
| Income Tax | $55M | $-424M | $-3M | $120M | $-212M | $-55M | $-10M | $-4M | $-65M | $91M | $-89M | $71M | $69M | $98M | $458M | $73M | |
| EPS (Basic) | $-0.10 | $0.15 | $-0.34 | $-0.11 | $0.00 | $-2.55 | $-0.44 | $0.08 | $-0.27 | $0.10 | $-0.64 | $0.28 | $0.22 | $0.19 | $0.83 | $0.29 | |
| EPS (Diluted) | $-0.10 | $0.15 | $-0.34 | $-0.11 | $0.00 | $-2.55 | $-0.43 | $0.08 | $-0.27 | $0.09 | $-0.63 | $0.27 | $0.22 | $0.19 | $0.83 | $0.29 | |
| Shares (Basic) | 1,163,300,000 | 1,155,400,000 | · | 1,164,600,000 | 1,173,000,000 | 1,192,400,000 | · | 1,193,500,000 | 1,191,100,000 | 1,195,200,000 | -2,400,700,000 | 1,199,500,000 | 1,199,000,000 | 1,202,500,000 | -2,423,200,000 | 1,212,500,000 | |
| Shares (Diluted) | 1,163,300,000 | 1,175,300,000 | · | 1,164,600,000 | 1,173,000,000 | 1,192,400,000 | · | 1,200,400,000 | 1,191,100,000 | 1,209,500,000 | -2,409,800,000 | 1,207,600,000 | 1,203,500,000 | 1,205,600,000 | -2,430,900,000 | 1,218,100,000 | |
| EBITDA | $6M | $596M | · | $179M | $233M | $-2.22B | · | $226M | $-240M | $895M | · | $452M | $369M | $1.13B | · | $560M |
बैलेंस शीट 28
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $886M | $1.80B | $1.32B | $975M | $566M | $755M | $735M | $1.88B | $917M | $1.01B | $992M | $1.31B | $629M | $507M | $1.26B | $647M | |
| Receivables | $3.13B | $3.08B | $3.03B | $3.37B | $3.26B | $3.13B | $3.22B | $3.72B | $3.57B | $3.63B | · | $3.74B | $3.61B | $3.50B | · | $3.33B | |
| Inventory | $3.93B | $3.93B | $4.00B | $4.11B | $4.26B | $4.10B | $3.85B | $4.08B | $3.94B | $3.82B | · | $3.67B | $3.64B | $3.66B | · | $3.38B | |
| Prepaid Expense | $2.11B | $2.11B | $1.44B | $1.49B | $1.69B | $1.65B | $1.71B | $1.63B | $1.76B | $1.93B | · | $1.78B | $1.73B | $1.76B | · | $1.70B | |
| Other Current Assets | $140M | $98M | $136M | $251M | $259M | $355M | $387M | $335M | $270M | $250M | · | $1.20B | $1.18B | $1.35B | · | $1.13B | |
| Current Assets | $10.06B | $10.92B | $9.79B | $9.95B | $9.77B | $9.62B | $9.52B | $11.31B | $11.79B | $12.92B | · | $10.93B | $9.78B | $9.63B | · | $10.49B | |
| PP&E (Net) | $2.44B | $2.53B | $2.61B | $2.63B | $2.64B | $2.64B | $2.67B | $2.68B | $2.66B | $2.71B | · | $2.93B | $2.98B | $3.01B | · | $3.04B | |
| PP&E (Gross) | $5.11B | $5.11B | $5.13B | $5.11B | $5.07B | $4.94B | $4.87B | $4.88B | $4.71B | $4.71B | · | $5.04B | $5.05B | $5.15B | · | $5.02B | |
| Accum. Depreciation | $2.67B | $2.58B | $2.52B | $2.48B | $2.42B | $2.30B | $2.20B | $2.21B | $2.05B | $2.00B | · | $2.11B | $2.06B | $2.14B | · | $1.98B | |
| Goodwill | $6.65B | $6.69B | $6.75B | $6.73B | $6.75B | $6.46B | $9.13B | $9.56B | $9.33B | $9.69B | $9.87B | $10.28B | $10.53B | $10.57B | $10.43B | $10.05B | |
| Intangibles | $13.68B | $14.48B | $15.10B | $15.72B | $16.32B | $16.66B | $17.07B | $17.98B | $18.42B | $19.13B | · | $21.28B | $22.08B | $22.70B | · | $23.01B | |
| Other Non-current Assets | $1.06B | $1.11B | $1.87B | $1.89B | $2.00B | $2.27B | $2.36B | $2.47B | $2.45B | $2.23B | · | $2.40B | $2.35B | $2.42B | · | $964M | |
| Total Assets | $35.04B | $36.83B | $37.19B | $37.92B | $38.41B | $38.47B | $41.50B | $44.75B | $45.33B | $47.34B | · | $48.74B | $48.70B | $49.29B | · | $48.66B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $100.0K | $23M | $205M | · | $500M | |
| Current Liabilities | $6.35B | $6.81B | $7.09B | $7.36B | $7.13B | $5.72B | $5.78B | $7.51B | $7.71B | $7.76B | · | $6.83B | $6.52B | $6.11B | · | $6.52B | |
| Capital Leases | $160M | $167M | $178M | $171M | $182M | $177M | $179M | $188M | $192M | $156M | · | $160M | $167M | $173M | · | $179M | |
| Deferred Tax | $803M | $871M | $892M | $1.03B | $1.08B | $1.08B | $1.11B | $1.28B | $1.57B | $1.67B | · | $2.32B | $2.41B | $2.46B | · | $2.49B | |
| Other Non-current Liabilities | $2.02B | $2.08B | $2.01B | $1.82B | $1.84B | $1.84B | $1.94B | $1.87B | $1.80B | $1.83B | · | $1.65B | $1.67B | $1.72B | · | $1.75B | |
| Total Liabilities | $20.78B | $22.18B | $22.48B | $22.70B | $22.84B | $22.82B | $22.87B | $24.96B | $25.81B | $27.33B | · | $27.88B | $27.85B | $28.36B | · | $29.48B | |
| Long-term Debt | $13.35B | $14.34B | $14.41B | $14.44B | $14.47B | $14.19B | $14.05B | $15.75B | $17.10B | $17.97B | · | $18.38B | $18.58B | $18.58B | · | $19.49B | |
| Total Debt | $13.35B | $14.34B | · | $14.44B | $14.47B | $14.19B | · | $15.75B | $17.10B | $17.97B | · | $18.38B | $18.60B | $18.78B | · | $19.99B | |
| Common Stock | $13M | $13M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | · | $12M | $12M | $12M | · | $12M | |
| Paid-in Capital | $18.56B | $18.66B | $18.80B | $18.89B | $19.00B | $18.96B | $18.92B | $18.89B | $18.85B | $18.84B | · | $18.76B | $18.72B | $18.68B | · | $18.62B | |
| Retained Earnings | $-331M | $-212M | $-388M | $-48M | $80M | $228M | $3.42B | $4.08B | $4.13B | $4.61B | · | $5.55B | $5.37B | $5.25B | · | $4.31B | |
| Treasury Stock | $1.16B | $1.01B | $1.01B | $924M | $856M | $680M | $504M | $504M | $504M | $504M | · | $252M | $252M | $252M | · | · | |
| AOCI | $-2.82B | $-2.80B | $-2.71B | $-2.71B | $-2.66B | $-2.87B | · | $-2.69B | $-2.98B | $-2.94B | · | $-3.21B | $-3.01B | $-2.76B | · | $-3.76B | |
| Stockholders' Equity | $14.26B | $14.66B | $14.71B | $15.22B | $15.57B | $15.65B | $18.64B | $19.79B | $19.52B | $20.01B | $20.47B | $20.87B | $20.84B | $20.93B | $21.07B | $19.18B | |
| Liabilities + Equity | $35.04B | $36.83B | $37.19B | $37.92B | $38.41B | $38.47B | $41.50B | $44.75B | $45.33B | $47.34B | · | $48.74B | $48.70B | $49.29B | · | $48.66B |
नकदी प्रवाह 17
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $672M | $676M | $767M | $688M | $678M | $665M | $746M | $670M | $786M | $691M | $644M | $679M | $687M | $730M | $870M | $700M | |
| Stock-based Comp | $39M | $48M | $49M | $36M | $37M | $55M | $32M | $32M | $35M | $47M | $56M | $43M | $39M | $43M | $30M | $29M | |
| Deferred Tax | $-124M | $-70M | $-248M | $-137M | $-48M | $-44M | $-249M | $-312M | $-154M | $-52M | $-207M | $-85M | $-68M | $-27M | $154M | $-22M | |
| Amort. of Intangibles | $572M | $585M | $602M | $593M | $583M | $571M | $579M | $575M | $597M | $601M | $539M | $584M | $591M | $603M | $606M | $616M | |
| Restructuring | $27M | $78M | · | · | · | · | · | · | · | · | · | $15M | $74M | $10M | · | $15M | |
| Operating Cash Flow | $382M | $388M | $816M | $745M | $220M | $536M | $483M | $826M | $379M | $615M | $568M | $845M | $525M | $971M | $189M | $869M | |
| CapEx | $53M | $40M | $196M | $87M | $53M | $43M | $140M | $77M | $59M | $50M | $166M | $96M | $68M | $48M | $154M | $104M | |
| Investing Cash Flow | $-52M | $277M | $-211M | $-99M | $-52M | $-65M | $-169M | $1.75B | $376M | $-154M | $27M | $-65M | $-87M | $-750M | $1.74B | $-115M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | $300.0K | $0 | $0 | $0 | $100.0K | $1.08B | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-750M | · | · | |
| Stock Issued | $700.0K | $500.0K | $600.0K | $700.0K | $700.0K | $600.0K | $600.0K | $600.0K | $700.0K | $600.0K | $600.0K | $800.0K | $800.0K | $900.0K | $800.0K | $2M | |
| Stock Repurchased | $150M | $0 | $82M | $68M | $175M | $175M | $0 | $0 | $0 | $250M | $0 | $0 | $0 | $250M | $0 | $0 | |
| Net Stock Activity | · | $500.0K | · | $-68M | $-175M | $-175M | · | · | · | $-249M | · | · | · | $-249M | · | · | |
| Financing Cash Flow | $-1.24B | $-204M | $-236M | $-228M | $-362M | $-467M | $-1.42B | $-1.64B | $-848M | $-426M | $-926M | $-98M | $-304M | $-975M | $-1.33B | $-759M | |
| Net Change in Cash | $-916M | $458M | $344M | $436M | $-188M | $20M | $-1.14B | $962M | $-97M | $22M | $-318M | $680M | $121M | $-752M | $612M | $-19M | |
| Free Cash Flow | · | $348M | · | · | · | $493M | · | · | · | $565M | · | · | · | $923M | · | · | |
| Levered FCF | · | $434M | · | · | · | $379M | · | · | · | $488M | · | · | · | $821M | · | · |
लाभप्रदता 5
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 38.8% | 32.9% | · | 36.5% | 37.2% | 35.7% | · | 38.9% | 38.1% | 41.0% | · | 42.9% | 41.0% | 41.4% | · | 42.9% | |
| Operating Margin | 0.17% | -2.3% | · | 4.8% | 6.5% | -88.6% | · | 6.0% | -6.3% | 5.6% | · | 11.5% | 9.4% | 10.7% | · | 13.7% | |
| Pretax Margin | -1.7% | -7.0% | · | -0.21% | -6.1% | -95.2% | · | 2.4% | -10.3% | 5.6% | · | 10.2% | 8.5% | 8.6% | · | 10.5% | |
| EBITDA Margin | 0.17% | 17.0% | · | 4.8% | 6.5% | -68.1% | · | 6.0% | -6.3% | 24.4% | · | 11.5% | 9.4% | 30.3% | · | 13.7% | |
| ROIC | 0.04% | 0.20% | · | 9.8% | 0.02% | -9.5% | · | 0.67% | -0.55% | 0.30% | · | 0.95% | 0.74% | 0.70% | · | 1.2% |
तरलता और शोधन क्षमता 5
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.6 | · | 1.4 | 1.4 | 1.7 | · | 1.5 | 1.5 | 1.7 | · | 1.6 | 1.5 | 1.6 | · | 1.6 | |
| Quick Ratio | 0.6 | 0.7 | · | 0.6 | 0.5 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.7 | 0.6 | 0.7 | · | 0.6 | |
| Debt / Equity | 0.9 | 1.0 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 1.0 | |
| LT Debt / Equity | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.9 | · | 0.7 | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.9 | · | 1.0 | |
| Interest Coverage | 0.1 | -0.7 | · | 1.5 | 2.0 | -25.0 | · | 1.6 | -1.6 | 1.5 | · | 3.2 | 2.6 | 2.7 | · | 3.7 |
दक्षता 3
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.6 | 0.6 | · | 0.6 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Receivables Turnover | 1.2 | 1.1 | · | 1.1 | 1.0 | 1.0 | · | 1.0 | 1.1 | 1.0 | · | 1.1 | 1.1 | 1.0 | · | 1.1 |
मूल्यांकन (TTM) 4
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14.62B | $14.11B | · | $14.35B | $14.38B | $14.47B | · | $15.15B | $15.32B | $15.25B | · | $15.67B | $15.84B | $16.12B | · | $16.92B | |
| Net Income TTM | $-170M | $-170M | · | $-170M | $-170M | $-170M | · | $-170M | $-170M | $-170M | · | $-170M | $-170M | $-170M | · | $-170M | |
| P/E | -264.7 | -5.4 | · | -3.8 | -3.3 | -3.3 | · | 68.3 | 34.3 | 15.5 | · | 10.2 | 10.4 | 9.0 | · | 7.5 | |
| Earnings Yield | -0.38% | -18.6% | · | -26.1% | -30.7% | -30.4% | · | 1.5% | 2.9% | 6.5% | · | 9.8% | 9.6% | 11.1% | · | 13.4% |
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
आय विवरण
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| राजस्व | $14.30B | $14.74B | $15.43B | $16.26B | $17.89B |
| सकल मार्जिन % | 35.1% | — | — | — | — |
| परिचालन मार्जिन % | -18.6% | — | — | — | — |
| शुद्ध आय | $-3.51B | $-634M | $55M | $2.08B | $-1.27B |
| तनुकरणित EPS | $-3.00 | $-0.53 | $0.05 | $1.71 | $-1.05 |
बैलेंस शीट
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| ऋण / इक्विटी | 1.0 | — | — | — | — |
| वर्तमान अनुपात | 1.4 | — | — | — | — |
| त्वरित अनुपात | 0.6 | — | — | — | — |
नकदी प्रवाह
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $1.94B | — | — | — | — |
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर पूर्ण फंडामेंटल में किसी भी पंक्ति के बगल में ➕ पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
संस्थागत मालिक (13F) 1132 फाइलर्स · $12.6B कुल · तिथि अनुसार 30 जून 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 113 (-40 पिछली तिमाही की तुलना में) | 87 (-1 पिछली तिमाही की तुलना में) | 354 (+16 पिछली तिमाही की तुलना में) | 313 (+7 पिछली तिमाही की तुलना में) | +106.4M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1590154649 | 127723265 | 12.66% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $1207625391 | 76046939 | 9.61% | शेयर |
| Davis Selected Advisers | $1194789797 | 75232254 | 9.51% | शेयर |
| FMR LLC | $992936353 | 62527478 | 7.90% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $861999430 | 54282080 | 6.86% | शेयर |
| STATE STREET CORP | $842743041 | 53069461 | 6.71% | शेयर |
| Rubric Capital Management LP | $542599639 | 34168743 | 4.32% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $458542313 | 28931625 | 3.65% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $425986168 | 26825324 | 3.39% | शेयर |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $320873980 | 20206170 | 2.55% | शेयर |
| AMERIPRISE FINANCIAL INC | $294863935 | 18568141 | 2.35% | शेयर |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $156853255 | 9877409 | 1.25% | शेयर |
| GOLDMAN SACHS GROUP INC | $138959750 | 8750614 | 1.11% | शेयर |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $132934942 | 8371218 | 1.06% | शेयर |
| Callodine Capital Management, LP | $127051783 | 8000742 | 1.01% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $103910383 | 6543475 | 0.83% | शेयर |
| Qube Research & Technologies Ltd | $98141941 | 6180223 | 0.78% | शेयर |
| Nantahala Capital Management, LLC | $79400000 | 5000000 | 0.63% | कॉल ऑप्शन |
| Assenagon Asset Management S.A. | $79225415 | 4989006 | 0.63% | शेयर |
| AMERICAN CENTURY COMPANIES INC | $73760258 | 4644851 | 0.59% | शेयर |
| FRANKLIN RESOURCES INC | $73433026 | 4624246 | 0.58% | शेयर |
| Gotham Asset Management, LLC | $69469966 | 4374683 | 0.55% | शेयर |
| Brandywine Global Investment Management, LLC | $67528501 | 5423976 | 0.54% | शेयर |
| NORGES BANK | $60705175 | 3822744 | 0.48% | शेयर |
| LAKEWOOD CAPITAL MANAGEMENT, LP | $59326092 | 3735900 | 0.47% | शेयर |
| BlackRock, Inc. | $50770853 | 3197157 | 0.40% | शेयर |
| RHUMBLINE ADVISERS | $45614656 | 2872464 | 0.36% | शेयर |
| Vanguard Global Advisers, LLC | $42862486 | 2699149 | 0.34% | शेयर |
| VICTORY CAPITAL MANAGEMENT INC | $42610407 | 2683275 | 0.34% | शेयर |
| FLPUTNAM INVESTMENT MANAGEMENT CO | $42249391 | 2660541 | 0.34% | शेयर |
| California Public Employees Retirement System | $40629123 | 2558509 | 0.32% | शेयर |
| ARGENT CAPITAL MANAGEMENT LLC | $40499641 | 2550355 | 0.32% | शेयर |
| DME Capital Management, LP | $39761614 | 2503880 | 0.32% | शेयर |
| Pictet Asset Management Holding SA | $39481647 | 2437987 | 0.31% | शेयर |
| ENVESTNET ASSET MANAGEMENT INC | $37396986 | 2354974 | 0.30% | शेयर |
| Swiss National Bank | $37102064 | 2336402 | 0.30% | शेयर |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $34474638 | 2170947 | 0.27% | शेयर |
| FIL Ltd | $33643336 | 2118598 | 0.27% | शेयर |
| Robeco Institutional Asset Management B.V. | $33037834 | 2080468 | 0.26% | शेयर |
| BARCLAYS PLC | $32535722 | 2048849 | 0.26% | शेयर |
| Allianz Asset Management GmbH | $32188236 | 2026967 | 0.26% | शेयर |
| Legal & General Group Plc | $31446226 | 1980241 | 0.25% | शेयर |
| BANK OF NOVA SCOTIA | $28130467 | 1771440 | 0.22% | शेयर |
| SEI INVESTMENTS CO | $28129290 | 1771366 | 0.22% | शेयर |
| BANK OF AMERICA CORP /DE/ | $28053767 | 1766610 | 0.22% | शेयर |
| BNP PARIBAS FINANCIAL MARKETS | $27953373 | 1760288 | 0.22% | शेयर |
| TORONTO DOMINION BANK | $27612303 | 1738810 | 0.22% | शेयर |
| Invenomic Capital Management LP | $27611985 | 1738790 | 0.22% | शेयर |
| Bridgewater Associates, LP | $26969655 | 1698341 | 0.21% | शेयर |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $26265777 | 1944173 | 0.21% | शेयर |
| RAYMOND JAMES FINANCIAL INC | $24676772 | 1553953 | 0.20% | शेयर |
| Camber Capital Management LP | $24557500 | 2750000 | 0.20% | शेयर |
| Arnhold LLC | $23200267 | 1460974 | 0.18% | शेयर |
| MANNING & NAPIER ADVISORS LLC | $23136612 | 1425546 | 0.18% | शेयर |
| Mitsubishi UFJ Asset Management Co., Ltd. | $22918445 | 1443227 | 0.18% | शेयर |
| MOORE CAPITAL MANAGEMENT, LP | $22718786 | 1430654 | 0.18% | शेयर |
| Quantinno Capital Management LP | $21730727 | 1368433 | 0.17% | शेयर |
| Quaker Capital Investments, LLC | $21567486 | 1358154 | 0.17% | शेयर |
| MOORE CAPITAL MANAGEMENT, LP | $21126752 | 1330400 | 0.17% | पुट ऑप्शन |
| STATE OF WISCONSIN INVESTMENT BOARD | $20950929 | 1319328 | 0.17% | शेयर |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $20773000 | 1308106 | 0.17% | शेयर |
| Man Group plc | $20719636 | 1304763 | 0.16% | शेयर |
| PRINCIPAL FINANCIAL GROUP INC | $19978215 | 1258074 | 0.16% | शेयर |
| Caption Management, LLC | $19850000 | 1250000 | 0.16% | पुट ऑप्शन |
| Monaco Asset Management SAM | $19287419 | 1214573 | 0.15% | शेयर |
| UBS Group AG | $18638340 | 1173699 | 0.15% | शेयर |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $18213709 | 1348165 | 0.15% | शेयर |
| ARCADIA INVESTMENT MANAGEMENT CORP/MI | $17959195 | 1329326 | 0.14% | शेयर |
| VANGUARD ASSET MANAGEMENT, Ltd | $17915228 | 1128163 | 0.14% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $17890408 | 1126600 | 0.14% | कॉल ऑप्शन |
| HIGHLAND PEAK CAPITAL, LLC | $17495488 | 1101731 | 0.14% | शेयर |
| THOMPSON INVESTMENT MANAGEMENT, INC. | $17330906 | 1091367 | 0.14% | शेयर |
| ALLIANCEBERNSTEIN L.P. | $16660991 | 1233234 | 0.13% | शेयर |
| Bastion Asset Management Inc. | $16191713 | 1052647 | 0.13% | शेयर |
| QSM Asset Management Ltd | $15898267 | 996132 | 0.13% | शेयर |
| TD Asset Management Inc | $15844127 | 997741 | 0.13% | शेयर |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $15495783 | 975805 | 0.12% | शेयर |
| Sio Capital Management, LLC | $15154268 | 954299 | 0.12% | शेयर |
| PRUDENTIAL FINANCIAL INC | $13466796 | 848035 | 0.11% | शेयर |
| Illinois Municipal Retirement Fund | $13448693 | 846895 | 0.11% | शेयर |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $13398528 | 843736 | 0.11% | शेयर |
| LEVIN CAPITAL STRATEGIES, L.P. | $13365809 | 841676 | 0.11% | शेयर |
| Woodline Partners LP | $12753911 | 803143 | 0.10% | शेयर |
| HSBC HOLDINGS PLC | $12656884 | 797033 | 0.10% | शेयर |
| EDMOND DE ROTHSCHILD HOLDING S.A. | $12545248 | 790003 | 0.10% | शेयर |
| CONTINENTAL ADVISORS LLC | $12430070 | 782750 | 0.10% | शेयर |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $11932326 | 751406 | 0.09% | शेयर |
| Miller Value Partners, LLC | $11642644 | 733164 | 0.09% | शेयर |
| ALGERT GLOBAL LLC | $11559052 | 727900 | 0.09% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11509824 | 724800 | 0.09% | पुट ऑप्शन |
| VestGen Advisors, LLC | $11228726 | 707099 | 0.09% | शेयर |
| Atom Investors LP | $11206246 | 705683 | 0.09% | शेयर |
| STOREBRAND ASSET MANAGEMENT AS | $10891425 | 685858 | 0.09% | शेयर |
| APG Asset Management N.V. | $10865473 | 782273 | 0.09% | शेयर |
| MARSHALL WACE, LLP | $10826793 | 681788 | 0.09% | शेयर |
| LPL Financial LLC | $10767536 | 678057 | 0.09% | शेयर |
| Poehling Capital Management, INC. | $10675322 | 672250 | 0.08% | शेयर |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $10620957 | 668826 | 0.08% | शेयर |
| CITADEL ADVISORS LLC | $10496680 | 661000 | 0.08% | कॉल ऑप्शन |
| Sound Income Strategies, LLC | $10242156 | 644972 | 0.08% | शेयर |
कंपनी के अंदरूनी सूत्र 31 इनसाइडर्स · 14 अधिकारी · 20 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Scott Andrew Smith | Chief Executive Officer | 6 मार्च 2026 A | 1329326 | 0 | 0 | $0 |
| Michael Goettler | Chief Executive Officer | 4 मार्च 2023 M | 321653 | 0 | 0 | $0 |
| Campbell Paul | Interim Chief Financial Officer, Chief Accounting Officer and Corporate Controller | 25 जून 2026 S | 316212 | 0 | 2 | $-1093257 |
| Theodora Mistras | Chief Financial Officer | 6 मार्च 2026 A | 70645 | 0 | 0 | $0 |
| Sanjeev Narula | Chief Financial Officer | 4 मार्च 2023 M | 73877 | 0 | 0 | $0 |
| Anthony Mauro | President, Developed Markets | 13 मार्च 2024 S | 243044 | 0 | 0 | $0 |
| Xiangyang (Sean) Ni | President, Greater China | 4 मार्च 2024 A | 90804 | 0 | 0 | $0 |
| Andrew Cuneo | President, JANZ (Japan, Australia and New Zealand) and Emerging Markets | 4 मार्च 2024 A | 60055 | 0 | 0 | $0 |
| Menassie Taddese | President, Emerging Markets | 27 मई 2022 S | 0 | 0 | 0 | $0 |
| Andrew Enrietti | Chief Administrative and Transformation Officer | 15 अगस्त 2026 M | 234444 | 0 | 0 | $0 |
| Corinne Le Goff | Chief Commercial Officer | 15 अप्रैल 2026 M | 107135 | 0 | 1 | $-72078 |
| Matthew Joseph Maletta | Chief Legal Officer | 6 मार्च 2026 A | — | 0 | 0 | $0 |
| Brian Roman | Chief Legal Officer | 6 मार्च 2025 A | 193916 | 0 | 0 | $0 |
| Robert J Coury | Executive Chairman | 4 मार्च 2023 M | 1174515 | 0 | 0 | $0 |
| Leo Frans Groothuis | निदेशक | 30 जून 2026 A | 63437 | 0 | 0 | $0 |
| David S Simmons | निदेशक | 30 जून 2026 A | 23344 | 2 | 0 | $5202 |
| Richard A Mark | निदेशक | 6 मार्च 2026 A | 116145 | 0 | 0 | $0 |
| Coelho Rogerio Vivaldi | निदेशक | 6 मार्च 2026 A | 46526 | 0 | 0 | $0 |
| Michael Severino | निदेशक | 6 मार्च 2026 A | 26031 | 0 | 0 | $0 |
| Dillon Joellen Lyons | निदेशक | 6 मार्च 2026 A | 102526 | 0 | 0 | $0 |
| Mark W Parrish | निदेशक | 6 मार्च 2026 A | 165230 | 0 | 0 | $0 |
| Elisha W Finney | निदेशक | 6 मार्च 2026 A | 62667 | 0 | 0 | $0 |
| Frank A Damelio | निदेशक | 6 मार्च 2026 A | 26031 | 0 | 0 | $0 |
| Don W Cornwell | निदेशक | 6 मार्च 2026 A | 112044 | 0 | 0 | $0 |
| Melina E Higgins | निदेशक | 6 मार्च 2026 A | 146048 | 0 | 0 | $0 |
| James M Kilts | निदेशक | 6 मार्च 2026 A | 161257 | 0 | 0 | $0 |
| Rajiv Malik | निदेशक | 6 मार्च 2025 A | 1068262 | 0 | 0 | $0 |
| Harry Korman | निदेशक | 6 मार्च 2025 A | 113937 | 0 | 0 | $0 |
| Mohr Pauline Van Der Meer | निदेशक | 4 मार्च 2023 M | 40245 | 0 | 0 | $0 |
| Ian C Read | निदेशक | 21 मार्च 2022 M | 14497 | 0 | 0 | $0 |
| Neil F Dimick | निदेशक | 21 मार्च 2022 M | 75200 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
ईटीएफ स्वामित्व 159 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| DUSA · Davis Fundamental ETF Trust | 4.97% | 3855281 NS | 30 अप्रैल 2026 | N-PORT |
| ADPV · Series Portfolios Trust | 4.11% | 471687 NS | 30 अप्रैल 2026 | N-PORT |
| DWLD · Davis Fundamental ETF Trust | 4.01% | 1522109 NS | 30 अप्रैल 2026 | N-PORT |
| LBAY · Tidal Trust I | 3.80% | 41162 NS | 31 मई 2026 | N-PORT |
| LYLD · Cambria ETF Trust | 2.12% | 8544 NS | 30 अप्रैल 2026 | N-PORT |
| SPDV · ETF Series Solutions | 2.08% | 125516 NS | 30 अप्रैल 2026 | N-PORT |
| ABIG · EA Series Trust | 1.97% | 67399 NS | 29 मई 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1.43% | 12352 NS | 30 अप्रैल 2026 | N-PORT |
| SYLD · Cambria ETF Trust | 1.03% | 662665 NS | 30 अप्रैल 2026 | N-PORT |
| BIB · ProShares Trust | 0.94% | 42565 NS | 31 मई 2026 | N-PORT |
| WBIG · Absolute Shares Trust | 0.72% | 12370 NS | 30 जून 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.71% | 6483864 NS | 30 अप्रैल 2026 | N-PORT |
| AVMV · AMERICAN CENTURY ETF TRUST | 0.66% | 251956 NS | 31 मई 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 0.65% | 7904043 NS | 30 अप्रैल 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 0.65% | 20246 NS | 30 अप्रैल 2026 | N-PORT |
| AUSF · Global X Funds | 0.55% | 287430 NS | 31 मई 2026 | N-PORT |
| ITAN · EA Series Trust | 0.51% | 27790 NS | 29 मई 2026 | N-PORT |
| ABCS · EA Series Trust | 0.50% | 3459 NS | 29 मई 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0.44% | 184557 NS | 30 अप्रैल 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.40% | 117672 NS | 30 अप्रैल 2026 | N-PORT |
| STNC · Hennessy Funds Trust | 0.40% | 24403 NS | 30 अप्रैल 2026 | N-PORT |
| AVLV · AMERICAN CENTURY ETF TRUST | 0.37% | 2917765 NS | 31 मई 2026 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0.35% | 3114448 NS | 31 मई 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.34% | 466740 NS | 30 अप्रैल 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.33% | 1672565 NS | 30 अप्रैल 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.31% | 91932 NS | 30 अप्रैल 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.28% | 530957 NS | 30 अप्रैल 2026 | N-PORT |
| RXL · ProShares Trust | 0.27% | 12010 NS | 31 मई 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0.27% | 67551 NS | 31 मई 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0.26% | 49318 NS | 30 अप्रैल 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0.25% | 22967 NS | 30 अप्रैल 2026 | N-PORT |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0.23% | 115075 NS | 30 अप्रैल 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.18% | 1127 NS | 31 मई 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0.18% | 37538 NS | 30 अप्रैल 2026 | N-PORT |
| TILT · FlexShares Trust | 0.17% | 228418 NS | 30 अप्रैल 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0.17% | 142548 NS | 30 अप्रैल 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0.15% | 43936 NS | 31 मई 2026 | N-PORT |
| FNDX · SCHWAB STRATEGIC TRUST | 0.15% | 2389096 NS | 31 मई 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0.14% | 113196 NS | 31 मई 2026 | N-PORT |
| SPXD · DBX ETF Trust | 0.14% | 575 NS | 31 मई 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0.14% | 495809 NS | 30 अप्रैल 2026 | N-PORT |
| FBCV · FIDELITY COVINGTON TRUST | 0.13% | 13443 NS | 30 अप्रैल 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.12% | 1165738 NS | 30 अप्रैल 2026 | N-PORT |
| AVLC · AMERICAN CENTURY ETF TRUST | 0.11% | 85902 NS | 31 मई 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.10% | 825526 NS | 31 मई 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.10% | 46227 NS | 31 मई 2026 | N-PORT |
| DEUS · DBX ETF Trust | 0.09% | 14298 NS | 29 मई 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.09% | 820931 NS | 30 अप्रैल 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.07% | 17604 NS | 30 अप्रैल 2026 | N-PORT |
| AFMC · First Trust Exchange-Traded Fund VI… | 0.06% | 6304 NS | 31 मई 2026 | N-PORT |